-+ 0.00%
-+ 0.00%
-+ 0.00%

EXCLUSIVE: SCIENTURE Secures Formulary Coverage For REZENOPY; Commercial Launch Planned For Mid-July

Benzinga·06/09/2026 11:45:25
Listen to the news

5,000+ Healthcare Facilities Reached Through
GPO Agreements, Covering ~60% of Institutional GPO Market
U.S. naloxone market totals ~$144 million in annual sales and ~9.8 million units annually,
represents significant commercial opportunity for REZENOPY™